CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis

European Journal of Neurology

Volumn 15, Issue 9, 2008, Pages 998-1001

  Chiasserini, D ^a   Di Filippo, M ^a,b   Candeliere, A ^a   Susta, F ^a   Orvietani, P L ^a   Calabresi, P ^a,b   Binaglia, L ^a   Sarchielli, P ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Cerebrospinal fluid; Clinically isolated syndrome; Multiple sclerosis; Proteomics

Indexed keywords

APOLIPOPROTEIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; CEREBROSPINAL FLUID PROTEINS; COHORT STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVOUS SYSTEM DISEASES; PREALBUMIN; PROTEOMICS;

EID: 49549111384     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02239.x     Document Type: Article

References (10)

1. Irani DN, Anderson C, Gundry R, et al. Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Annals of Neurology 2006 59 : 237 247.
2. Hammack BN, Fung KY, Hunsucker SW, et al. Proteomic analysis of multiple sclerosis cerebrospinal fluid. Multiple Sclerosis 2004 10 : 245 260.
3. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001 50 : 121 127.
4. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 33 : 144 152.
5. Oakley BR, Kirsch DR, Morris NR. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Analytical Biochemistry 1980 105 : 361 363.
6. Goffette S, Schluep M, Henry H, Duprez T, Sindic CJ. Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 2004 75 : 308 310.
7. Lehmensiek V, Süssmuth SD, Tauscher G, et al. Cerebrospinal fluid proteome profile in multiple sclerosis. Multiple Sclerosis 2007 13 : 840 849.
8. Mischak H, Apweiler R, Banks RE, et al. Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clinical Application 2007 1 : 148 156.
9. Del Boccio P, Pieragostino D, Lugaresi A, et al. Cleavage of cystatin C is not associated with multiple sclerosis. Annals of Neurology 2007 62 : 201 204.
10. Hansson SF, Simonsen AH, Zetterberg H, et al. Cystatin C in cerebrospinal fluid and multiple sclerosis. Annals of Neurology 2007 62 : 193 196.